Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial

Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial

Item
http://www.wikidata.org/entity/Q56838211
Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21Therapeutic cancer vaccines and combination immunotherapies involving vaccinationAn integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers.Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy.Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaquesSynergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma.Role of IL-21 and IL-21 receptor on B cells in HIV infection.Immunomodulatory cytokines as therapeutic agents for melanomaAntigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?IL-21: a pleiotropic cytokine with potential applications in oncology.Interleukin 21 - its potential role in the therapy of B-cell lymphomas.IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells.
P2860

Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial

Item
http://www.wikidata.org/entity/Q56838211
description
im Oktober 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 19 October 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2010
@uk
name
Safety and Clinical Effect of ...... ell Carcinoma: A Phase I Trial
@en
Safety and Clinical Effect of ...... ell Carcinoma: A Phase I Trial
@nl
type
label
Safety and Clinical Effect of ...... ell Carcinoma: A Phase I Trial
@en
Safety and Clinical Effect of ...... ell Carcinoma: A Phase I Trial
@nl
prefLabel
Safety and Clinical Effect of ...... ell Carcinoma: A Phase I Trial
@en
Safety and Clinical Effect of ...... ell Carcinoma: A Phase I Trial
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Safety and clinical effect of ...... ell carcinoma: a phase I trial
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-10-1809
P407
P433
P478
P50
P577
P698
P921